You are here

Arena

Acceleron’s post-Reblozyl plan comes together

EP Vantage

Tue, 01/28/20 - 11:09 am

Bellerophon Therapeutics

United Therapeutics

Arena: Belviq Advertising Slips - Sales Continue To Slip As Well

Seeking Alpha

Fri, 09/4/15 - 10:26 am

Arena: Belviq Sales Flattening Out - Is It Sector Saturation?

Seeking Alpha

Wed, 05/20/15 - 10:31 am

Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus

TheStreet.com

Sat, 02/21/15 - 09:44 am

3 Pharma Companies Fighting Obesity

Yahoo/Benzinga

Thu, 10/30/14 - 05:33 pm

The Future of Fat Fighting: Next-Gen Obesity Drugs

Motley Fool

Sun, 05/25/14 - 10:30 am

Arena Sees Growth Continue With Belviq

Seeking Alpha

Sat, 03/8/14 - 10:28 am

This Week in Biotech

Motley Fool

Sun, 11/10/13 - 12:56 pm

Arena's Belviq Sales Pass 4,000 On IMS

Seeking Alpha

Sat, 10/5/13 - 09:29 am

Arena Week 11 Sales Up Big

Seeking Alpha

Sat, 08/31/13 - 10:28 am

Trade-Ideas: Arena Pharmaceuticals (ARNA) Is Today's "Dead Cat Bounce" Stock

The Street

Sat, 08/31/13 - 10:27 am

Why This Obesity Drug Is the Sector's Best Bet

Motley Fool

Fri, 05/24/13 - 10:49 am

An Obesity Drugmaker's Critical Coming Weeks

Motley Fool

Sun, 04/14/13 - 12:14 pm

It's Now Time For Vivus Investors To Watch Arena Numbers

Seeking Alpha

Thu, 02/28/13 - 11:28 am

Arena's Marketing Partner Eisai Pharma Seeks Expedited Final Ruling From DEA To Begin Belviq Sales

Seeking Alpha

Mon, 12/24/12 - 10:37 am

The Looming EU Approval Makes Arena Pharmaceuticals Significantly Undervalued

Motley Fool

Sun, 12/16/12 - 10:18 am

This Week in Biotech

Motley Fool

Sun, 11/25/12 - 11:15 am

MAP Pharmaceuticals

Good News for Vivus and Arena

Motley Fool

Sat, 11/24/12 - 11:37 am

Science Arena Investors Need to Know

Motley Fool

Sat, 09/22/12 - 02:19 pm

Arena And Vivus Set To Dominate The Obesity Drug Market

Seeking Alpha

Thu, 08/30/12 - 09:58 am

Pages